Expansion through partnerships NeoStem has been actively partnering with organizations like Catalent Pharma Solutions, Kuva Labs, Valo Therapeutics, University of Cincinnati, and Haystack Oncology, indicating potential collaborative sales opportunities in the pharmaceutical industry.
Focus on innovative therapies As a clinical-stage pharmaceutical company dedicated to developing therapies for advanced solid tumors and other major diseases, NeoStem's cutting-edge approach presents sales prospects for institutions seeking novel treatment solutions.
Engagement in industry events NeoStem's participation in prominent events like the 2025 BIO CEO & Investor Conference and the Sequire Investor Summit suggests opportunities for sales professionals to network, showcase products, and engage with key stakeholders in the biotechnology sector.
Research collaboration opportunities By engaging in sponsored research agreements with academic institutions like the University of Cincinnati and companies like Valo Therapeutics, NeoStem opens avenues for sales teams to explore collaborative opportunities and showcase products for research purposes.
Utilization of advanced technology With a tech stack including Akamai, WordPress, Shopify, and others, NeoStem demonstrates a reliance on technology for various functions, indicating potential sales opportunities for tech companies offering complementary services or products.
$10M
$1B
$1B
$1B
$50M$100MNeoStem uses 8 technology products and services including Akamai, WordPress, Webpack, and more. Explore NeoStem's tech stack below.
| NeoStem Email Formats | Percentage |
| FLast@caladrius.com | 42% |
| Last@caladrius.com | 31% |
| First.Last@caladrius.com | 14% |
| First@caladrius.com | 6% |
| FirstLast@caladrius.com | 5% |
| LFirst@caladrius.com | 1% |
| FirLast@caladrius.com | 1% |
| FirstLast@lisata.com | 57% |
| FLast@lisata.com | 29% |
| FirLast@lisata.com | 14% |
Biotechnology ResearchNew Jersey, United States11-50 Employees
Lisata Therapeutics is a U.S. clinical-stage pharmaceutical company (Nasdaq: LSTA) dedicated to the discovery, development, and commercialization of innovative therapies for the treatment of advanced solid tumors and other major diseases.
Company Overview
Media & News
Funding & FinancialsNeoStem has raised a total of $1.4M of funding over 11 rounds. Their latest funding round was raised on May 12, 2021 in the amount of $1.4M.
NeoStem's revenue is in the range of $10M
Funding & FinancialsNeoStem has raised a total of $1.4M of funding over 11 rounds. Their latest funding round was raised on May 12, 2021 in the amount of $1.4M.
NeoStem's revenue is in the range of $10M
1-888-653-2347 
support@leadiq.com